Innovation
8 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 371 times.
| Year | Filings |
|---|---|
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 6 |
Investor mix
7 investors on record; lead investors include Co-win Ventures, Jemincare, Fujian Haixi New Drug Creation.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 57% |
| Other / undisclosed | 3 | 43% |